Login / Signup

Combined treatment of AT101 and demethoxycurcumin yields an enhanced anti-proliferative effect in human primary glioblastoma cells.

Moiken MehnerCarolin KubeltVivian AdamskiChristina SchmittMichael SynowitzJanka Held-Feindt
Published in: Journal of cancer research and clinical oncology (2019)
Combined treatment with different drugs might be an option to efficiently overcome chemoresistance of GBM cells in a long-term treatment strategy.
Keyphrases
  • induced apoptosis
  • endothelial cells
  • combination therapy
  • replacement therapy
  • drug induced